Open Access
Volume 7, 2021
Article Number 63
Number of page(s) 16
Section Knee
Published online 17 December 2021

© The Authors, published by EDP Sciences, 2021

Licence Creative CommonsThis is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Total knee arthroplasty (TKA) and anterior cruciate ligament (ACL) reconstruction surgeries are two of the most performed orthopedic operations in the world [14]. TKA cases, revisions, and revisions per surgeon have all significantly increased in the last 10 years [2, 5]; ACL reconstruction has similarly become more prevalent over the last 30 years, particularly in the pediatric population, corresponding with the United States’ increase in youth sports injuries [1, 3, 6].

While both procedures are considered highly efficacious, with TKA having shown a 10- to 15-year implant survivorship rate of over 90% [2], and up to 92% of ACL reconstruction patients receiving “A” or “B” outcome scores in a 2018 systematic review by Sarraj et al. [6], they are both operations consistently associated with moderate to severe postoperative pain [1, 4]. Exposed by this are the sub-par anesthetic and analgesic perioperative pain management interventions used in the field of orthopedic surgery.

According to Li et al. 2019 review, a multimodal approach is currently considered best practice for TKA pain management [7, 8]. This approach subjects the patient to a wide variety of anesthetic and analgesic medications, including preemptive analgesia, neuraxial anesthesia, peripheral nerve blocks, patient controlled-analgesia, local infiltration analgesia, gabapentanoids, periarticular injections, non-steroidal anti-inflammatory drugs (NSAIDs), and opioids [7, 8]. A similar multimodal approach is currently used peri- and postoperatively for ACL reconstructions, highlighted by intra-articular injections, peripheral nerve blocks, regional anesthesia, oral gabapentanoids, and once again, the heavy use of NSAIDs and opioid medications [911].

The main downfall of both approaches is the heavy reliance on opioids, a strong and addictive class of painkillers associated with massive negative side effects [12]. Opioids present a high risk for misuse and abuse, with rates of misuse having been shown as up to 56.3% and addiction rates as high as 23.0% in prescribed users [12]. Rates of opioid-dependence disorders, non-medical opioid use, unauthorized distribution, and accidental overdoses have all skyrocketed in the United States over the past 25 years [13].

Additionally, the United States is in the middle of the world’s largest opioid epidemic [1318], single-handedly consuming 80% of the world’s opioid supply [20]. More than 4% of the countries’ adult population currently misuses opioids [14], with 92% of these individuals misusing only physician-prescribed opioids and no other controlled substances [15], leading to an average of 130 Americans dying every day from opioid overdose [16]. Further, treatment of dependence, abuse, and overdose cases costs the United States economy up to $78.5 billion every year. Orthopedic surgery alone accounts for approximately 8.8% of postoperative opioid dependence cases in previously opioid-naive patients [19], prescribing more opioids than almost any other medical specialty [20].

The current multimodal analgesic approach mentioned above for both TKA and ACL reconstruction has attempted to combat this epidemic by lessening opioid use [711]; however, NSAIDs are the main alternative in these pain management strategies, which are also subject to severe negative consequences [2123]. Harirforoosh et al. showed that NSAIDs could cause adverse effects in the gastrointestinal, cardiovascular, and renal systems [22] that limit or contraindicate NSAID use. NSAIDs have also been linked to postoperative bone and musculoskeletal soft tissue healing deficiencies, which is very concerning in orthopedic patients [21, 23].

The combination of the opioid epidemic and lack of viable alternative, long-term pharmacologic analgesics highlights the demanding need for a non-pharmacologic analgesic intervention in the perioperative period. An alternative non-pharmacologic analgesic working to the same efficacy as opioids and NSAIDs could, in theory, completely replace said drugs to manage pain in TKA and ACL reconstruction operations, ending orthopedic surgeries’ large contribution to the United States opioid crisis.

All of that said, non-pharmacologic perioperative analgesia is a very novel field of research, and the current literature is very limited. This systematic review intended to highlight and synthesize the available literature in the field, aiming to serve as a template for future research, effectively speeding up the process of establishing an efficacious non-pharmacologic analgesic for major knee surgery.

In doing so, the effectiveness of percutaneous peripheral nerve stimulation, percutaneous cyroneurolysis (percutaneous freezing of sensory nerves), and auricular acupressure were comparatively evaluated.


Systematic review methodology

A systematic search of the published literature was performed based on PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines for studies published before July 9th, 2020.

A Medical Subject Heading (MeSH) plus keyword search was performed across PubMed, MEDLINE, Embase, Cochrane, and Web of Science. The MEDLINE search was conducted as follows:

((Exp Electric Stimulation Therapy/ OR Exp Audioanalgesia/ OR (Nonpharmacologic* OR “non-pharmacologic*” OR Cryoanalges* OR cryoneuro* OR Neuromodulat* OR electrostimulat* OR “electric* stimulation” OR “electrical muscle stimulation” OR “interferential current” OR electroacupuncture OR “nerve stimulation” OR audioanalges* OR analgesi* OR (pain adj2 manag*)).ti,ab) AND ((Exp Arthroplasty, Replacement, Knee/ OR ((exp Knee/ OR exp Knee Joint/) AND (exp Arthroplasty/)) OR TKA.ti,ab OR (knee adj2 (replacement* OR arthroplast*)).ti,ab) OR ((Exp Anterior Cruciate Ligament Injuries/ OR exp anterior cruciate ligament/ OR ACL.ti,ab OR “anterior cruciate ligament”.ti,ab) AND (surgery.ti,ab OR reconstruction.ti,ab OR surgery.fs OR exp Surgical Procedures, Operative/)))) AND (perioperative.ti,ab OR “peri operative”.ti,ab OR (immediate* adj2 (postoperative OR “post operative”)).ti,ab OR exp Perioperative Care/ OR exp Perioperative Period/)

The articles obtained were then evaluated based on strict inclusion and exclusion criteria. Studies were included that focused on (1) analyzing the efficacy of a non-pharmacologic peri- or immediate postoperative intervention for TKA or ACL reconstruction operations, (2) analyzing the effect of said interventions on short and long-term postoperative opioid use, (3) analyzing the clinical and functional outcomes of procedures in patients treated with said interventions, and (4) used human patients.

Studies were excluded based on the following criteria: (1) focusing on operations other than TKA or ACL reconstruction; (2) focusing on patients who were previously diagnosed with opioid addiction; (3) analyzing the efficacy of a pharmacologic (drug-based) intervention; (4) analyzing the efficacy of a non-pharmacologic intervention used in the rehabilitation phase (after the immediate postoperative period).

All studies were screened independently based on the previously stated criteria. Articles were screened initially by title and then abstract, after which the full text of all remaining manuscripts was reviewed. All full-text manuscripts determined as meeting criteria were included for analysis.

Outcomes of interest

The primary outcome of interest in the presented study was patients’ postoperative opioid use. Secondary outcomes of interest includes non-opioid postoperative medication use, pain scores, and clinical and functional surgical outcomes. These measures were intended to determine the ramifications of non-pharmacologic analgesia usage on the effectiveness of each operation.

Quality of evidence

Each of the six included studies was also assessed for risk-of-bias: randomized controlled trials (RCTs) were assessed using the Revised Cochrane Risk-of-Bias Tool for Randomized Trials [24], case series were assessed using the Checklist for Quality Assessment of Non-Randomized Studies developed by Brazzelli et al. [25], and the retrospective chart review was assessed using Cochranes Tool to Assess Risk-of-Bias in Cohort Studies [26]. This assessment breakdown is represented visually in Tables 24. Overall potential risk-of-bias ratings for each study included low risk, high risk, or some concern [24].

Subsequently, the overall body of evidence was assessed using the GRADE (Grades of Recommendation, Assessment, Development, and Evaluation) criteria for each primary and secondary outcome. As such, the authors evaluated the evidence for each outcome based on study type, risk-of-bias, and the precision, consistency, and directness of the data. All GRADE assessment categories and outcomes evaluated can be seen in Table 5. The potential GRADE score for each outcome ranged from high quality to very low quality. Further, each outcome was rated as critical, important, or not important.


Study selection

Database searches resulted in a total of 1902 publications to be screened. Initially, duplicates were removed, resulting in 1354 remaining papers. These papers were first screened by title – where 1116 papers were excluded, then abstract – where 211 more papers were excluded. Finally, full-text manuscripts of the remaining 27 publications were screened, and 6 were deemed to fit inclusion criteria. Figure 1 illustrates the screening process.

thumbnail Figure 1.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [42] illustrating the manuscript identification and screening process.

Quality of evidence

The six included studies consisted of two RCTs [27, 28], three case series [2931], and one retrospective chart review [32]. The risk-of-bias in each study were all determined to be either “low risk” or “some concern” (Tables 24).

GRADE quality of evidence was assessed for five separate outcomes: postoperative opioid use, other postoperative analgesic use, pain scores, clinical outcomes, and functional outcomes. The quality of evidence was rated as “low” for all, primarily due to the small sample sizes of most included studies, and all outcomes were graded as either “critical” or “important” (Table 5).

Introduction to included studies: operations and non-pharmacologic analgesics investigated

Five included studies investigated the effects of non-pharmacologic analgesics on TKA patients [27, 2932], while one studied ACL reconstruction patients [28]. Sample sizes ranged from a case series of 3 patients [31], to a 100-patient clinical trial [32]; details are shown in Table 1.

Table 1.

Cumulative data for all studies fitting inclusion criteria.

Three of these studies investigated the efficacy of percutaneous peripheral nerve stimulation, two percutaneous cryoneurolysis, and one auricular acupressure (Table 1). Lastly, the period of treatment and measurement ranged from five days preoperatively to six weeks postoperatively.

Postoperative use of opioids and other pharmacologic analgesics

As seen in Table 1, five of the six included studies showed a significant decrease in opioid use for the treatment group, as compared to controls [27, 2932]; the final study did not directly measure opioid consumption compared to control groups, so statistical significance could not be obtained. Even so, only 50% of patients in the final study undergoing peripheral nerve stimulation requested simultaneous opioids [28].

All three non-pharmacologic interventions proved successful at reducing postoperative opioid consumption. That said, the most overall success was seen in the Ilfeld et al. percutaneous peripheral nerve stimulation study, in which they showed a median time to opioid cessation of only six days [29].

Only Ilfeld et al. in 2018 reported on other pharmacologic analgesic medication usage, showing that 7/10 patients elected to turn on a canal nerve block to supplement non-pharmacologic treatment. However, the same paper also showed more encouraging data in that 8/10 patients elected to use an optional perineural injection analgesic on postoperative days (POD) 1 and 2, but only 3/10 patients still required the same treatment on POD 3 [28], suggesting peripheral nerve stimulation quickly became an independently successful analgesic intervention.

Postoperative pain scores

All six included studies showed their respective interventions to be successful analgesics as measured by postoperative pain scores [2732]. Only He et al. and Dasa et al. compared non-pharmacologic interventions to positive control groups, both reporting significantly lower pain scores for patients in the non-pharmacologic intervention condition [27, 32]. That said, Dasa et al. showed that cryoneurolysis treatment significantly decreased pain scores at all postoperative time points measured. Comparatively, He et al. auricular acupressure treatment was no more successful than the control for the first 48 h after surgery but reached statistical significance from day 3 onward, suggesting cryoneurolysis may be superior to auricular acupressure in the direct perioperative period [27, 32]. All other included studies reported mild pain scores for almost all treatment group patients (defined as <4/10 on a self-report pain scale) [2831], the details of these results are outlined in Table 1.

Clinical and functional outcomes

Clinical outcomes should be considered very important secondary outcomes for novel non-pharmacologic perioperative analgesics because it ensures that any successes with respect to reduced opioid consumption and pain management do not come at the expense of the primary operational goal. Four included studies reported data on the clinical outcome of each operation [27, 29, 30, 32]. As seen in Table 1, all four studies showed significant clinical improvement after surgery [27, 29, 30, 32]. While the variability in reporting mechanism makes direct comparisons between non-pharmacologic analgesic interventions difficult, consistency over time suggests that cryoneurolysis and percutaneous peripheral nerve stimulation are more successful than auricular acupressure in promoting positive clinical outcomes [27, 29, 30, 32], albeit to a small degree. Notably, none of the interventions negatively affect clinical outcomes [27, 29, 30, 32].

Functional outcomes of each operation were also analyzed as a secondary outcome. Five out of six studies reported such data [2731]. As detailed in Table 1, all five studies (spanning auricular acupressure, cryoneurolysis, and percutaneous peripheral nerve stimulation) reported positive functional outcomes [2731].


Non-pharmacologic analgesic interventions reduce opioid use and manage peri- and postoperative pain

Cryoneurolysis, percutaneous peripheral nerve stimulation, and auricular acupressure all have the capability to successfully reduce postoperative opioid use in major knee surgery [2732]. While small sample sizes make a direct comparison difficult, it appears that peripheral nerve stimulation may have a small primary advantage in reducing opioid consumption over the other two interventions. This interpretation is primarily based on the data (Table 1) showing that percutaneous peripheral nerve stimulation leads to a slim majority of patients (13/25 total) discontinuing opioid use within the first postoperative week or not requesting opioids at all [2830]. The stated timeline is more drastic than any time to opioid cessation data from cryoneurolysis or auricular acupressure (though cryoneurolysis follows closely behind). However, the effect is almost certainly not significant, and there is a degree of variation within percutaneous peripheral nerve stimulation studies – one having shown a median time to opioid cessation of 6 days [29], and another 16.5 days [30]. Previous large-scale RCTs have shown the control group median time to opioid cessation in orthopedic surgery to range from 32 to 39 days postoperatively [33, 34], suggesting that the presented studies show large improvement from baseline levels. Moreover, it makes many patients who stopped taking opioids within the first week or forewent opioids completely more noteworthy.

Time to cessation of opioid use is an extremely important measure of non-pharmacologic analgesic success because opioid use of more than 31 days postoperatively is associated with a greater likelihood of chronic opioid use one year after surgery [35]. All non-pharmacologic analgesics assessed in the present study proved to be opioid-sparing [2732]. Therefore, this data does not necessarily exhibit any superiority of results amongst the three modalities reviewed in this paper, but heavily emphasizes the advantages of utilizing any of these interventions over opioids.

Similarly, cryoneurolysis and percutaneous peripheral nerve stimulation reduced postoperative pain scores earlier in the perioperative period than did auricular acupressure [2732]. Auricular acupressure reduced pain scores at POD 3 and beyond [27], but cryoneurolysis and percutaneous peripheral nerve stimulation did so immediately on POD 1 [2832]. This early pain relief may have greater implications than just patient comfort, as higher pain on the day of surgery is a significant predictor of chronic, postoperative opioid use [36]. Thus, an even greater opioid reduction advantage may be seen in implementing cryoneurolysis or percutaneous peripheral nerve stimulation over auricular acupressure.

Surgical outcomes

It is inherently important to ensure any novel analgesic does not negatively affect surgical outcomes. As such, it is of great significance that none of the presented non-pharmacologic interventions worsened clinical or functional outcomes following major knee surgery [2732].

One major difference is noteworthy in that cryoneurolysis was the only modality to show improved clinical outcomes over a control group [32]; with significant improvements seen in the treatment group for KOOS Symptoms Subscale scores and postoperative length of stay [32]. Alternatively, percutaneous peripheral nerve stimulation and auricular acupressure only showed significant improvement in clinical or functional outcomes compared to preoperative baselines [2730]. While such improvement certainly maintains the analgesic viability of percutaneous peripheral nerve stimulation and auricular acupressure, it simultaneously indicates a distinct advantage to cryoneurolysis. The identified gap in clinical outcomes can most likely be attributed to the robust ability of cryoneurolysis to decrease pain in the perioperative period [31, 32], avoiding uncontrolled pain, which leads to slower patient mobilization and a delayed start to rehabilitation, worsening clinical outcomes after TKA and ACL reconstruction [37, 38]. It has also been shown that preemptive analgesia can lessen the postoperative inflammatory response and perioperative pain [39, 40]. Fittingly, cryoneurolysis is the only of the three non-pharmacologic analgesics analyzed to be fully administered prior to surgery [29, 31].

The most efficacious non-pharmacologic analgesic interventions

As alluded to above, cryoneurolysis, percutaneous peripheral nerve stimulation, and auricular acupressure appear to all be viable analgesic interventions for TKA and ACL reconstruction surgeries. That said, the presented data suggest that cryoneurolysis, closely followed by percutaneous peripheral nerve stimulation, maybe the most beneficial to implement in clinical settings.

Cryoneurolysis is the most successful intervention at inhibiting peri- and postoperative pain [31, 32]. Both cryoneurolysis and percutaneous peripheral nerve stimulation showed immediate postoperative analgesic efficacy [2832], but cryoneurolysis separates as the most efficacious intervention because patients in such trials also exhibited slightly lower pain scores than those who underwent percutaneous peripheral nerve stimulation, while maintaining significant decreases in postoperative opioid use [31, 32]. Cryoneurolysis is also the only analyzed non-pharmacologic analgesic to improve clinical outcomes [32]. As detailed in Tables 25, cryoneurolysis also shows the strongest quality of evidence for included interventions. Combined with the factors described above, this leads to the conclusion that cryoneurolysis, followed in order by percutaneous peripheral nerve stimulation and auricular acupressure, is the most promising novel perioperative non-pharmacologic analgesic intervention for implementation into clinical use.

Table 2.

ROB assessment for randomized controlled trials: Revised Cochrane ROB tool for Randomized Trials.

Table 3.

ROB/quality assessment for case series.

Table 4.

ROB assessment for retrospective chart review.

Table 5.

GRADE evidence profile.

Limitations of the presented studies

While considering all the presented data, it is also important to recognize the limitations of each study. Most limitations in the presented systematic review stem from the novelty of perioperative non-pharmacologic analgesic research. The largest overall limitation is the small number of suitable studies and small sample sizes investigated in said studies. As shown in Table 1, the two included studies were relatively large, with over 90 participants, but the remainder all had 18 or fewer. The small sizes led to other limitations, such as one study not having attempted to determine statistical significance [28], and two others having elected to statistically compare novel interventions to historical controls instead of a positive control group [30, 31]. Lastly, four of the six included studies were performed by the same first author [2831]. While that fact limits the generalizability of the presented conclusions, the authors still deemed it apt to include all four of the studies for two reasons: (1) given the novelty of the field and a small amount of available literature, these studies also make up much of the literature regarding perioperative non-pharmacologic analgesics, and (2) all four of the studies met the systematic review’s inclusion criteria.

Implications of the data

As highlighted in the Introduction section, the primary benefit of a successful perioperative non-pharmacologic analgesic would be to replace opioids as the primary postoperative analgesic in major knee surgery. Doing so would eliminate the vast negative effects of opioid use, including concerningly high misuse and abuse rates in prescribed users and a high frequency of adverse side effects [12]. Moreover, this is of particular importance to orthopedic researchers as the United States is currently in the middle of the world’s worst opioid epidemic [1318], with opioid addiction and overdose rates rising rapidly over the last quarter-century and orthopedic surgery being the single largest prescribing medical specialty [19, 20]. Fortunately, the data presented in this systematic review indicates that several non-pharmacologic interventions may be viable to replace opioids as the primary perioperative analgesic for TKA and ACL reconstruction operations.

Direction of future research

Future research into perioperative non-pharmacologic analgesics is certainly warranted. The first and most telling research that should be performed is to implement full-scale, multi-site RCTs for cryoneurolysis and percutaneous peripheral nerve stimulation. While the data from pilot studies are very promising, RCTs would drastically improve the reliability of results seen and overcome the available literature’s current issue with small sample sizes. Moreover, it would be very telling to measure longer-term follow-ups, allowing researchers to determine if there are any negative long-term effects on nerve function from either cryoneurolysis or percutaneous peripheral nerve stimulation. Although studies utilizing cryoneurolysis to treat chronic pain have shown it to be safe and reversible over time [41], so completing these long-term studies may not be as pressing.

Other interesting extensions of the presented studies would be determining if an additive or synergistic effect can be seen by simultaneously implementing auricular acupressure and either cryoneurolysis or percutaneous peripheral nerve stimulation. Lastly, a notable distinction exists in the presented papers evaluating cryoneurolysis and percutaneous peripheral nerve stimulation that some utilize ultrasound guidance for implementation, and some do not. While it seems reasonable that ultrasound guidance is safer and allows for more detailed lead placement, similar results were seen in the presented review for studies including or excluding ultrasound guidance. Hence, a trial directly comparing outcomes for these groups would be important in setting clinical best practices.


The present systematic review aimed to analyze and compare the available literature on perioperative non-pharmacologic analgesic interventions in the hopes of advancing a novel field of orthopedic research, with the end goal of lessening postoperative opioid use after TKA and ACL reconstruction operations. As such, the authors conclude that cryoneurolysis, percutaneous peripheral nerve stimulation, and auricular acupressure all appear to be viable and successful non-pharmacologic analgesics in the perioperative period. Of the three, cryoneurolysis seems the most promising moving into future research.

Conflict of interest

R. Juncker: The author declares that they have no relevant financial or non-financial interests to report.

F. Mirza: The author declares that they have no relevant financial or non-financial interests to report.

J. Gagnier: The author declares that they have no relevant financial or non-financial interests to report.


This research did not receive any specific funding.

Ethical approval

Ethical approval was not required.

Informed consent

This article does not contain any studies performed by the authors involving human subjects.

Author contributions

R. Juncker: Conceptualization, Methodology, Investigation, Writing original draft, Reviewing and Editing; F. Mirza: Conceptualization, Methodology, Investigation, Reviewing and Editing; J. Gagnier: Conceptualization, Methodology, Investigation, Reviewing and Editing


  1. Siegel L, Vandenakker-Albanese C, Siegel D (2012) Anterior cruciate ligament injuries: anatomy, physiology, biomechanics, and management. Clin J Sport Med 22(4), 349–355. [Google Scholar]
  2. Delanois RE, Mistry JB, Gwam CU, Mohamed NS, Choksi US, Mont MA (2017) Current epidemiology of revision total knee arthroplasty in the United States. J Arthroplasty 32(9), 2663–2668. [Google Scholar]
  3. Mall NA, Chalmers PN, Moric M, Tanaka MJ, Cole BJ, Bach BR Jr, Paletta GA Jr (2014) Incidence and trends of anterior cruciate ligament reconstruction in the United States. Am J Sports Med 42(10), 2363–2370. [Google Scholar]
  4. Hasegawa M, Tone S, Naito Y, Wakabayashi H, Sudo A (2019) Prevalence of persistent pain after total knee arthroplasty and the impact of neuropathic pain. J Knee Surg 32(10), 1020–1023. [Google Scholar]
  5. Bozic KJ, Kamath AF, Ong K, Lau E, Kurtz S, Chan V, Vail TP, Rubash H, Berry DJ (2015) Comparative epidemiology of revision arthroplasty: failed THA poses greater clinical and economic burdens than failed TKA. Clin Orthop Relat Res 473(6), 2131–2138. [Google Scholar]
  6. Sarraj M, de Sa D, Shanmugaraj A, Musahl V, Lesniak BP (2019) Over-the-top ACL reconstruction yields comparable outcomes to traditional ACL reconstruction in primary and revision settings: a systematic review. Knee Surg Sports Traumatol Arthrosc 27(2), 427–444. [Google Scholar]
  7. Li JW, Ma YS, Xiao LK (2019) Postoperative pain management in total knee arthroplasty. Orthop Surg 11(5), 755–761. [Google Scholar]
  8. Elmallah RK, Chughtai M, Khlopas A, Newman JM, Stearns KL, Roche M, Kelly MA, Harwin SF, Mont MA (2018) Pain control in total knee arthroplasty. J Knee Surg 31(6), 504–513. [Google Scholar]
  9. Secrist ES, Freedman KB, Ciccotti MG, Mazur DW, Hammoud S (2016) Pain management after outpatient anterior cruciate ligament reconstruction: a systematic review of Randomized Controlled Trials. Am J Sports Med 44(9), 2435–2447. [Google Scholar]
  10. Abdallah FW, Brull R, Joshi GP (2019) Pain management for ambulatory arthroscopic anterior cruciate ligament reconstruction: evidence-based recommendations from the Society for Ambulatory Anesthesia. Anesth Analg 128(4), 631–640. [Google Scholar]
  11. Rao AG, Chan PH, Prentice HA, Paxton EW, Funahashi TT, Maletis GB (2019) Risk factors for opioid use after anterior cruciate ligament reconstruction. Am J Sports Med 47(9), 2130–2137. [Google Scholar]
  12. Vowles KE, McEntee ML, Julnes PS, Frohe T, Ney JP, van der Goes DN (2015) Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 156(4), 569–576. [Google Scholar]
  13. Stoicea N, Costa A, Periel L, Uribe A, Weaver T, Bergese SD (2019) Current perspectives on the opioid crisis in the US Healthcare System: a comprehensive literature review. Medicine (Baltimore) 98(20), e15425. [Google Scholar]
  14. Skolnick P (2018) The opioid epidemic: crisis and solutions. Annu Rev Pharmacol Toxicol 58, 143–159. [Google Scholar]
  15. Lyden J, Binswanger IA (2019) The United States opioid epidemic. Semin Perinatol 43(3), 123–131. [Google Scholar]
  16. Reider B (2019) Opioid Epidemic. Am J Sports Med 47(5), 1039–1042. [Google Scholar]
  17. Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP (2016) The opioid epidemic in the United States. Emerg Med Clin North Am 34(2), e1–e23. [Google Scholar]
  18. Shipton EA, Shipton EE, Shipton AJ (2018) A review of the opioid epidemic: What do we do about it? Pain Ther 7(1), 23–36. [Google Scholar]
  19. Trasolini NA, McKnight BM, Dorr LD (2018) The opioid crisis and the orthopedic surgeon. J Arthroplasty 33(11), 3379–82.e1. [Google Scholar]
  20. Leopold SS, Beadling L (2017) Editorial: The opioid epidemic and orthopaedic surgery-no pain, Who gains? Clin Orthop Relat Res 475(10), 2351–2354. [Google Scholar]
  21. Ghosh N, Kolade OO, Shontz E, Rosenthal Y, Zuckerman JD, Bosco JA 3rd, Virk MS (2019) Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and their effect on musculoskeletal soft-tissue healing: a scoping review. JBJS Rev 7(12), e4. [Google Scholar]
  22. Harirforoosh S, Asghar W, Jamali F (2013) Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications. J Pharm Sci 16(5), 821–847. [Google Scholar]
  23. Lisowska B, Kosson D, Domaracka K (2018) Positives and negatives of nonsteroidal anti-inflammatory drugs in bone healing: the effects of these drugs on bone repair. Drug Des Devel Ther 12, 1809–1814. [Google Scholar]
  24. Cochrane Bias RoB 2: A Revised Cochrane Risk-of-Bias Tool for Randomized Trials. [Google Scholar]
  25. Brazzelli M, Cruickshank M, Tassie E, et al. (2015) Collagenase clostridium histolyticum for the treatment of Dupuytren’s contracture: systematic review and economic evaluation. NIHR Journals Library: Southampton (UK). (Health Technology Assessment, No. 19.90.) Appendix 5, Risk-of-bias checklist: case series. Available from: [Google Scholar]
  26. Cochrane. Tool to Assess Risk of Bias in Cohort Studies. [Google Scholar]
  27. He BJ, Tong PJ, Li J, Jing HT, Yao XM (2013) Auricular acupressure for analgesia in perioperative period of total knee arthroplasty. Pain Med 14(10), 1608–1613. [Google Scholar]
  28. Ilfeld BM, Said ET, Finneran JJ IV, et al. (2019) Ultrasound-guided percutaneous peripheral nerve stimulation: neuromodulation of the femoral nerve for postoperative analgesia following ambulatory anterior cruciate ligament reconstruction: a proof of concept study. Neuromodulation 22(5), 621–629. [Google Scholar]
  29. Ilfeld BM, Ball ST, Gabriel RA, et al. (2019) A feasibility study of percutaneous peripheral nerve stimulation for the treatment of postoperative pain following total knee arthroplasty. Neuromodulation 22(5), 653–660. [Google Scholar]
  30. Ilfeld BM, Ball ST, Cohen SP, Hanling SR, Fowler IM, Wongsarnpigoon A, Boggs JW (2019) Percutaneous peripheral nerve stimulation to control postoperative pain, decrease opioid use, and accelerate functional recovery following orthopedic trauma. Mil Med 184(Suppl 1), 557–564. [Google Scholar]
  31. Ilfeld BM, Gabriel RA, Trescot AM (2017) Ultrasound-guided percutaneous cryoneurolysis providing postoperative analgesia lasting many weeks following a single administration: a replacement for continuous peripheral nerve blocks? A case report. Korean J Anesthesiol 70(5), 567–570. [Google Scholar]
  32. Dasa V, Lensing G, Parsons M, Harris J, Volaufova J, Bliss R (2016) Percutaneous freezing of sensory nerves prior to total knee arthroplasty. Knee 23(3), 523–528. [Google Scholar]
  33. Hah JM, Cramer E, Hilmoe H, et al. (2019) Factors associated with acute pain estimation, postoperative pain resolution, opioid cessation, and recovery: secondary analysis of a Randomized Clinical Trial. JAMA Netw Open 2(3), e190168. [Google Scholar]
  34. Hah J, Mackey SC, Schmidt P, et al. (2018) Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort: a Randomized Clinical Trial. JAMA Surg 153(4), 303–311. [Google Scholar]
  35. Hills JM, Carlile CR, Archer KR, et al. (2020) Duration and dosage of opioids after spine surgery: implications on outcomes at 1 Year. Spine (Phila Pa 1976) 45(15), 1081–1088. [Google Scholar]
  36. Goesling J, Moser SE, Zaidi B, Hassett AL, Hilliard P, Hallstrom B, Clauw DJ, Brummett CM (2016) Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain 157(6), 1259–1265. [Google Scholar]
  37. Rutherford RW, Jennings JM, Dennis DA. 2017. Enhancing recovery after total knee arthroplasty. Orthop Clin North Am 48(4), 391–400. [Google Scholar]
  38. Łyp M, Stanisławska I, Witek B, Majerowska M, Czarny-Działak M, Włostowska E (2018) The timing of rehabilitation commencement after reconstruction of the anterior cruciate ligament. Adv Exp Med Biol 1096, 53–57. [Google Scholar]
  39. Wall PD (1988) The prevention of postoperative pain. Pain 33(3), 289–290. [Google Scholar]
  40. Scott WN (2011) Insall & Scott Surgery of the Knee E-Book. Elsevier Health Sciences. [Google Scholar]
  41. Smiley A, McGuire J (2018) Cryoneurolysis for the treatment of sensory nerve pain. AANA J 86(6), 495–503. [Google Scholar]
  42. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6(7), e1000097. [Google Scholar]

Cite this article as: Juncker RB, Mirza FM & Gagnier JJ (2021) Reduction in opioid use with perioperative non-pharmacologic analgesia in total knee arthroplasty and ACL reconstruction: a systematic review. SICOT-J 7, 63

All Tables

Table 1.

Cumulative data for all studies fitting inclusion criteria.

Table 2.

ROB assessment for randomized controlled trials: Revised Cochrane ROB tool for Randomized Trials.

Table 3.

ROB/quality assessment for case series.

Table 4.

ROB assessment for retrospective chart review.

Table 5.

GRADE evidence profile.

All Figures

thumbnail Figure 1.

Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram [42] illustrating the manuscript identification and screening process.

In the text

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.